Reply to letter to editor on "Expectant management of borderline ovarian tumor during pregnancy"
Arch Gynecol Obstet
.
2021 Dec;304(6):1625.
doi: 10.1007/s00404-021-06271-9.
Authors
Ailyn M Vidal Urbinati
1
,
Anna D Iacobone
2
3
,
Dorella Franchi
2
Affiliations
1
Preventive Gynecology Unit, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy. ailyn.vidalurbinati@ieo.it.
2
Preventive Gynecology Unit, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
3
Department of Biomedical Sciences, University of Sassari, 07100, Sassari, Italy.
PMID:
34622338
DOI:
10.1007/s00404-021-06271-9
No abstract available
Publication types
Letter
Comment
MeSH terms
Female
Humans
Ovarian Neoplasms*
Ovulation Induction
Pregnancy
Pregnancy Rate
Watchful Waiting*